Protective effects of melanocortins in systemic host reactions

Advances in Experimental Medicine and Biology

Volumn 681, Issue , 2010, Pages 117-125

  Gatti, Stefano ^a   Lonati, Caterina ^b   Sordi, Andrea ^b   Catania, Anna ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AFAMELANOTIDE; ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; ASPARAGINYLASPARTYLPROLINE ALPHA INTERMEDIN; CORTICOTROPIN; CORTICOTROPIN[1-24]; CORTICOTROPIN[1-39]; CYCLOOXYGENASE 2; CYSTEINYLLYSYLPROLYLVALINE; GENTAMICIN; GLUTAMATE SODIUM; HP 228; INTERLEUKIN 1; INTERLEUKIN 6; MELANOCORTIN; MELANOCORTIN RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PARACETAMOL; PROSTAGLANDIN E2; PYROGEN; TETRACOSACTIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AMINO ACID SEQUENCE; ANTIPYRETIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN ISCHEMIA; CELL ACTIVATION; CONCENTRATION RESPONSE; DRUG POTENCY; DRUG TARGETING; ENDOTOXEMIA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; FEVER; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEPATITIS; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE ISCHEMIA; KIDNEY INJURY; KIDNEY ISCHEMIA; LUNG EDEMA; MEDIAL PREOPTIC AREA; MONOTHERAPY; NONHUMAN; ORGAN TRANSPLANTATION; PERITONITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REPERFUSION INJURY; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERMOREGULATION;

ANIMALS; HUMANS; MELANOCORTINS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 79959560884     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6354-3_9     Document Type: Article

References (70)

1. Dinarello CA. Infection, fever and exogenous and endogenous pyrogens: Some concepts have changed. J Endotoxin Res 2004; 10:201-222. (Pubitemid 39481010)
2. Steiner AA, Chakravarty S, Rudaya AY et al. Bacterial lipopolysaccharide fever is initiated via Toll-like receptor 4 on hematopoietic cells. Blood 2006; 107:4000-4002. (Pubitemid 43726807)
3. Lipton JM, Glyn JR, Zimmer JA. Hypothermic and antipyretic effects of centrally administered ACTH(1-24) and α-melanotropin. Fed Proc 1981; 40:2760-2762.
4. Tatro JB, Sinha PS. The central melanocortin system and fever. Ann N Y Acad Sci 2003; 994:246-257. (Pubitemid 36793874)
5. Davidson J, Milton AS, Rotondo D. Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit. J Physiol 1992; 451:491-502.
6. Martin LW, Catania A, Hiltz ME et al. Neuropeptide alpha-MSH antagonizes IL-6- and TNF-induced fever. Peptides 1991; 12:297-299.
7. Martin LW, Deeter LB, Lipton JM. Acute-phase response to endogenous pyrogen in rabbit: Effects of age and route of administration. Am J Physiol 1989; 257:R189-193.
8. Shih ST, Lipton JM. Intravenous alpha-MSH reduces fever in the squirrel monkey. Peptides 1985; 6:685-687. (Pubitemid 16195050)
9. Holdeman M, Lipton JM. Antipyretic activity of a potent alpha-MSH analog. Peptides 1985; 6:273-275. (Pubitemid 15051829)
10. Murphy MT, Lipton JM. Peripheral administration of alpha-MSH reduces fever in older and younger rabbits. Peptides 1982; 3:775-779. (Pubitemid 13171616)
11. Murphy MT, Richards DB, Lipton JM. Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone. Science 1983; 221:192-193. (Pubitemid 13063866)
12. Catania A, Lipton JM. Peptide modulation of fever and inflammation within the brain. Ann N Y Acad Sci 1998; 856:62-68. (Pubitemid 28517337)
13. Glyn JR, Lipton JM. Hypothermic and antipyretic effects of centrally administered ACTH(1-24) and α-melanotropin. Peptides 1981; 2:177-187. (Pubitemid 11030841)
14. Richards DB, Lipton JM. Antipyretic doses of α-MSH do not alter afebrile body temperature in the cold. J Thermal Biol 1984; 9:299-301. (Pubitemid 15179856)
15. Zimmer JA, Lipton JM. Central and peripheral injections of ACTH (1-24) reduce fever in adrenalectomized rabbits. Peptides 1981; 2:419-423.
16. Murphy MT, Richards DB, Lipton JM. Antipyretic potency of centrally administered α-melanocyte stimulating hormone. Science 1983; 221:192-193. (Pubitemid 13063866)
17. Martin LW, Lipton JM. Acute phase response to endotoxin: Rise in plasma α-MSH and effects of α-MSH injection. Am J Physiol 1990; 259:R768-R772. (Pubitemid 20352350)
18. Goelst K, Mitchell D, Laburn H. Effects of alpha-melanocyte stimulating hormone on fever caused by endotoxin in rabbits. J Physiol 1991; 441:469-476.
19. Huang QH, Hruby VJ, Tatro JB. Systemic α-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. Am J Physiol 1998; 275:R524-530.
20. Villar M, Perassi N, Celis ME. Central and peripheral actions of α-MSH in the thermoregulation of rats. Peptides 1991; 12:1441-1443.
21. Robertson BA, Gahring LC, Daynes RA. Neuropeptide regulation of interleukin-1 activities. Capacity of α-melanocyte stimulating hormone to inhibit interleukin-1 inducible responses in vivo and in vitro exhibits target cell selectivity. Inflammation 1986; 10:371-385. (Pubitemid 17179595)
22. Daynes RA, Robertson BA, Cho BH et al. Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro. J Immunol 1987; 139:103-109. (Pubitemid 17091769)
23. Hori T, Nakashima T, Take S et al. Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 1991; 27:309-313.
24. Richards DB, Lipton JM. Effect of α-MSH(11-13) (lysine-proline- valine) on fever in the rabbit. Peptides 1984; 5:815-817. (Pubitemid 14058564)
25. Deeter LB, Martin LW, Lipton JM. Antipyretic properties of centrally administered α-MSH fragments in the rabbit. Peptides 1989; 9:1285-1288. (Pubitemid 19265219)
26. Samson WK, Lipton JM, Zimmer JA. The effect of fever on central α-MSH concentrations in the rabbit. Peptides 1981; 2:419-423. (Pubitemid 12145749)
27. Holdeman M, Khorram O, Samson WK et al. Fever specific changes in MSH and CRF concentrations. Am J Physiol 1985; 248:R125-R129. (Pubitemid 15172503)
28. Bell RC, Lipton JM. Pulsatile release of antipyretic neuropeptide α-MSH from septum of rabbit during fever. Am J Physiol 1987; 252:R1152-R1157.
29. Glyn-Ballinger JR, Bernardini GL, Lipton JM. α-MSH injected into the septal region reduces fever in rabbits. Peptides 1983; 4:199-203. (Pubitemid 13047884)
30. Feng JD, Dao T, Lipton JM. Effects of preoptic microinjections of alpha-MSH on fever and normal temperature control in rabbits. Brain Res Bull 1987; 18:473-477. (Pubitemid 17115925)
31. Shih ST, Khorram O, Lipton JM et al. Central administration of α-MSH antiserum augments fever in the rabbit. Am J Physiol 1986; 250:R803-R806.
32. Opp MR, Obal F, Kreuger JM. Effects of α-MSH on sleep, behavior and brain temperature: Interactions with IL-1. Am J Physiol 1988; 255:R914-R922.
33. Martin SA, Malkinson TJ, Veale WL et al. Depletion of brain α-MSH alters prostaglandin and interleukin fever in rats. Brain Res 1990; 526.
34. Huang QH, Entwistle ML, Alvaro JD et al. Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever. J Neurosci 1997; 17:3343-3351. (Pubitemid 27175845)
35. Tatro JB. Endogenous antipyretics. Clin Infect Dis 2000; 31(Suppl)5:S190-201. (Pubitemid 32291110)
36. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008; 8:32-43.
37. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009; 37:291-304.
38. Martin LW, Lipton JM. Acute phase response to endotoxin: Rise in plasma alpha-MSH and effects of alpha-MSH injection. Am J Physiol 1990; 259:R768-772. (Pubitemid 20352350)
39. Delgado Hernandez R, Demitri MT, Carlin A et al. Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte-stimulating hormone. Neuroimmunomodulation 1999; 6:187-192. (Pubitemid 29193029)
40. Abou-Mohamed G, Papapetropoulos A, Ulrich D et al. HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro. J Pharmacol Exp Ther 1995; 275:584-591. (Pubitemid 26025546)
41. Lipton JM, Ceriani G, Macaluso A et al. Antiinflammatory effects of the neuropeptide alpha-MSH in acute, chronic and systemic inflammation. Ann N Y Acad Sci 1994; 741:137-148.
42. Chiao H, Foster S, Thomas R et al. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996; 97:2038-2044. (Pubitemid 26143957)
43. Pepys MB, Rogers SL, Evans DJ. Role of the acute phase response in the Shwartzman phenomenon. Clin Exp Immunol 1982; 47:289-295. (Pubitemid 12207786)
44. Scholzen TE, Sunderkotter C, Kalden DH et al. Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 2003; 144:360-370. (Pubitemid 36076126)
45. Capsoni F, Ongari A, Colombo G et al. The synthetic melanocortin (CKPV)2 exerts broad anti-inflammatory effects in human neutrophils. Peptides 2007; 28:2016-2022. (Pubitemid 47432811)
46. Gatti S, Carlin A, Sordi A et al. Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions. J Surg Res 2006; 131:209-214.
47. Ichiyama T, Zhao H, Catania A et al. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 1999; 157:359-365. (Pubitemid 29260743)
48. Haycock JW, Wagner M, Morandini R et al. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human melanocytes and melanoma cells. J Invest Dermatol 1999; 113:560-566. (Pubitemid 29489617)
49. Manna SK, Aggarwal BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 1998; 161:2873-2880. (Pubitemid 28425709)
50. Colombo G, Gatti S, Sordi A et al. Production and effects of alpha-melanocyte-stimulating hormone during acute lung injury. Shock 2007; 27:326-333. (Pubitemid 46277052)
51. Shen AS, Haslett C, Feldsien DC et al. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am Rev Respir Dis 1988; 137:564-571. (Pubitemid 18081631)
52. Matthay MA, Robriquet L, Fang X. Alveolar epithelium: Role in lung fluid balance and acute lung injury. Proc Am Thorac Soc 2005; 2:206-213. (Pubitemid 41500847)
53. Guarini S, Schioth HB, Mioni C et al. MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias. Naunyn Schmiedebergs Arch Pharmacol 2002; 366:177-182. (Pubitemid 34762278)
54. Bazzani C, Mioni C, Ferrazza G et al. Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia/reperfusion injury. Resuscitation 2002; 52:109-115. (Pubitemid 34098991)
55. Bazzani C, Guarini S, Botticelli AR et al. Protective effect of melanocortin peptides in rat myocardial ischemia. J Pharmacol Exp Ther 2001; 297:1082-1087. (Pubitemid 32472507)
56. Huh SK, Lipton JM, Batjer HH. The protective effects of alpha-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 1997; 40:132-139; discussion 139-140.
57. Huang Q, Tatro JB. Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice. Neurosci Lett 2002; 334:186-190. (Pubitemid 35350857)
58. Chiao H, Kohda Y, McLeroy P et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997; 99:1165-1172. (Pubitemid 27142751)
59. Kwon TH, Frokiaer J, Han JS et al. Decreased abundance of major Na() transporters in kidneys of rats with ischemia-induced acute renal failure. Am J Physiol Renal Physiol 2000; 278:F925-939. (Pubitemid 30441358)
60. Deng J, Kohda Y, Chiao H et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001; 60:2118-2128. (Pubitemid 33070455)
61. Jo SK, Yun SY, Chang KH et al. Alpha-MSH decreases apoptosis in ischaemic acute renal failure in rats: Possible mechanism of this beneficial effect. Nephrol Dial Transplant 2001; 16:1583-1591. (Pubitemid 32750449)
62. Chiao H, Kohda Y, McLeroy P et al. Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 1998; 54:765-774. (Pubitemid 28397394)
63. Hassoun HT, Zou L, Moore FA et al. Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002; 282:G1059-1068. (Pubitemid 34651613)
64. Lipton JM, Catania A, Ichiyama T. Marshaling the anti-inflammatory influence of the neuroimmunomodulator alpha-MSH. News Physiol Sci 2000; 15:192-195.
65. Kwon TH, Frokiaer J, Fernandez-Llama P et al. Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure: Prevention by alpha-MSH. Am J Physiol 1999; 277:F413-427. (Pubitemid 29459654)
66. Pascual M, Swinford RD, Ingelfinger JR et al. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today 1998; 19:514-519.
67. Dallman MJ. Immunobiology of graft rejection. In: Ginns LC, Cosimi AB, Morris PJ, eds. Transplantation. Malden, MA: Blackwell Science, 1999;23-35.
68. Gatti S, Colombo G, Buffa R et al. Alpha-melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 2002; 74:1678-1684. (Pubitemid 36019317)
69. Colombo G, Gatti S, Turcatti F et al. Gene expression profiling reveals multiple protective influences of the peptide {alpha}-melanocyte-stimulating hormone in experimental heart transplantation. J Immunol 2005; 175:3391-3401. (Pubitemid 41170562)
70. Colombo G, Sordi A, Lonati C et al. Treatment with alpha-melanocyte stimulating hormone preserves calcium regulatory proteins in rat heart allografts. Brain Behav Immun 2008; 22:817-823.